Physician profile
Robert Lemery
NPI 1992288567
$6,634.91
in general payments reported to CMS, 2019-2025
14 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $2,905 · 2021: $1,768 · 2022: $688 · 2023: $349 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,505.54 | 2019-2022 | |
| Biosense Webster, INC. | $2,181.61 | 2019-2025 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $242.07 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $233.56 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $127.66 | 2022 | |
| Medtronic, INC. | $104.80 | 2021 | |
| Atricure, INC. | $69.09 | 2019 | |
| Impulse Dynamics (USA) INC. | $40.80 | 2021 | |
| Astellas Pharma US INC | $38.15 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.13 | 2019 | |
| Boston Scientific Corporation | $18.99 | 2020 | |
| Zoll Respicardia, INC. | $17.77 | 2023 | Remede System |
| E.R. Squibb & Sons, L.L.C. | $16.10 | 2020 | |
| Stryker Corporation | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lemery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.